At a glance
ClinicalIndex Comparison RecordPhase 1Completed· 19 enrolled
Drug / intervention
PLENVU powder for oral solutiondrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Pharmacokinetic Study of PLENVU® in Healthy Subjects
In Brief
A Phase 1 clinical trial evaluating PLENVU powder for oral solution for Pharmacokinetic. Completed, enrolled 19 participants across 1 site.
Detailed Summary
This study characterises the pharmacokinetic (PK) profile of the active ingredients of PLENVU (NER1006) and their related substances/metabolites. Subjects will receive PLENVU.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPharmacokinetic
CountriesUnited Kingdom
CollaboratorsQuotient Sciences
Timeline
Phase 1CompletedFinished
201820192020202120222023202420252026
First PostedFeb 2018
Enrollment StartSep 2020
Primary CompletionOct 2020
TodayJul 2026
First PostedFeb 19, 2018
Enrollment StartSep 3, 2020
Primary CompletionOct 5, 2020
TodayJul 2, 2026
Enrollment to primary: 1 monthPosted 8.4 years ago
Interventions
PLENVU powder for oral solutiondrug
PLENVU Dose 1 (1 sachet) and PLENVU Dose 2 (2 sachets)